Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Ability Biotherapeutics logo — Developing innovative targeted immuno therapeutics to addres...

Ability Biotherapeutics

Developing innovative targeted immuno therapeutics to addressing unmet medical needs for cancer and autoimmune diseases

Founded 2023 Canada Montreal, Canada 25 employees Seed Total: $30.00M Biotechnology, Life Sciences

General Information

Company Name Ability Biotherapeutics
Founded Year 2023
Location Canada Montreal, Canada
Employees 25
Industries Biotechnology, Life Sciences
Funding Stage Seed
Business Model B2B, Platform
Revenue Model Licensing, Performance Based, Product Sales
Social

BounceWatch is an independent company data service, not affiliated with Ability Biotherapeutics. To contact Ability Biotherapeutics, visit ability.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Ability Biotherapeutics compare?

A PDF of Ability Biotherapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Ability Biotherapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Ability Biotherapeutics

Ability Biotherapeutics is an innovative company established in 2023 and headquartered in Canada. Operating within the Biotechnology and Life Sciences industries, the company's slogan captures its groundbreaking approach: "Developing innovative targeted immuno therapeutics to address unmet medical needs for cancer and autoimmune diseases."

The core mission of Ability Biotherapeutics involves the development of cutting-edge, targeted, and immune-modulating biotherapeutics. Their unique AbiLeap™ discovery engine leverages AI and a comprehensive antigen-antibody interaction database to produce human, IgG-based multispecific antibodies. These antibodies exhibit high selectivity and affinity, functioning in response to cellular microenvironment signals.

In its recent Seed Round on June 18, 2024, the company raised $6.00M from notable investors like Alexandria Venture Investments, Amplitude Ventures, and Investissement Québec, showing strong market confidence in its potential.

Business keywords: Targeted Immunotherapy, Cancer Treatment, Autoimmune Diseases, Biotherapeutics, Antibody Development, AI-Driven Drug Discovery, AbiLeap Discovery Engine, Multispecific Antibodies, Human IgG Antibodies, Immune Modulating Therapies, Antigen-Antibody Interactions, Logic-Gated Therapeutics, Cellular Microenvironment Response, AI/ML in Biotech, Biotech Innovation

Services & Products

Development of precision therapies
Immune cell modulating biotherapeutics
Antibody discovery and engineering
Product candidates pipeline

Target Customers

Biopharmaceutical companies Research institutions Healthcare providers Patients with inflammatory diseases Cancer patients

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed $18.00M 6
Alexandria Venture Investments Amplitude Ventures NVEST VENTURE
Alexandria Venture Investments, Amplitude Ventures +4
01 Jun 2024
Seed $12.00M 1
Amplitude Ventures
Amplitude Ventures
01 Dec 2023

Ability Biotherapeutics Alternatives & Competitors

View All Alternatives
Ability Biotherapeutics vs
Anavo Therapeutics BV
Anavo Therapeutics BV The Netherlands

UNLOCKING THE PHOSPHATASE TARGET CLASS

Seed
24 employees
Biotechnology, Health and Wellness
Compare Ability Biotherapeutics vs Anavo Therapeutics BV
Ability Biotherapeutics vs
ImCheck Therapeutics
ImCheck Therapeutics France

Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic

Grant
57 employees
Biopharma, Biotechnology
Compare Ability Biotherapeutics vs ImCheck Therapeutics
Ability Biotherapeutics vs
ExeVir
ExeVir Belgium

Rapid Viral control in a world that needs it

Grant
10 employees
Biotechnology, Health Care
View all alternatives

FAQ About Ability Biotherapeutics

Developing innovative targeted immuno therapeutics to addressing unmet medical needs for cancer and autoimmune diseases
Ability Biotherapeutics was founded in 2023.
Ability Biotherapeutics is headquartered in Montreal, Canada.
Ability Biotherapeutics operates in Biotechnology and Life Sciences. Its work centres on Targeted Immunotherapy, Cancer Treatment, Autoimmune Diseases and Biotherapeutics. Its customers include Biopharmaceutical companies, Research institutions and Healthcare providers.
Ability Biotherapeutics has a B2B and Platform business model. Its revenue comes from Licensing, Performance Based and Product Sales.
Ability Biotherapeutics has approximately 25 employees.
Ability Biotherapeutics has completed 2 funding rounds, raising a total of $30.00M. The latest funding stage is Seed.
Ability Biotherapeutics offers: Development of precision therapies, Immune cell modulating biotherapeutics, Antibody discovery and engineering, Product candidates pipeline.
Top alternatives and competitors to Ability Biotherapeutics include Anavo Therapeutics BV, ImCheck Therapeutics, ExeVir, Sensei Bio, Bright Peak Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ability Biotherapeutics and Anavo Therapeutics BV are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Ability Biotherapeutics, https://bouncewatch.com/company/ability-biologics, updated 27 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes